By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Atritech, Inc. 

3750 Annapolis Lane, Suite 105

Plymouth  Minnesota  55447  U.S.A.
Phone: 763-746-5022 Fax: 763-258-0253


Medical Device

Company News
Boston Scientific Corporation (BSX) Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech, Inc. 3/3/2011 6:46:26 AM
Boston Scientific Corporation (BSX) to Acquire Atritech, Inc.; Agreement Calls for Upfront Payment of $100M Plus Potential Payments of up to $275M 1/19/2011 6:50:00 AM
Atritech, Inc. Enrolls First Patient Into PREVAIL Study 11/3/2010 6:48:23 AM
Atritech, Inc. Announces FDA Regulatory Update 3/19/2010 11:12:24 AM
Atritech, Inc. Announces FDA Regulatory Update; Confirmatory Study Required for Final FDA Approval 3/19/2010 7:00:31 AM
FDA Advisory Panel Votes 7 To 5 To Recommend Approval Of Atritech, Inc.'s Watchman LAA Closure Device 4/23/2009 10:14:03 PM
US FDA Staff Cites Issues With Atritech, Inc. Device Data 4/21/2009 5:44:51 PM
Atritech, Inc. Completes $30 Million Financing 3/26/2009 9:23:35 AM
Atritech, Inc. Files Pre-Market Approval Application for Its WATCHMAN(R) LAA Closure Technology Enrolls first patient in Continued Access Registry 8/18/2008 10:02:14 AM
Atritech, Inc. Announces Completion of a $22 Million Equity Financing 9/5/2007 9:30:42 AM